Glycorex operating loss widens to SEK 4.2 million in Q2 FY26; net sales fall to SEK 6.7 million

• Glycorex Transplantation posted Q2 net sales of SEK 6.7 million, down 34.31% year on year.
• Operating loss widened to SEK 4.2 million from SEK 1 million a year earlier.
• Net loss widened to SEK 4.3 million; loss per share deepened to SEK 0.05.
• H1 net sales fell 22.22% to SEK 15.4 million; operating loss widened to SEK 7.6 million.
• Unit sales dropped 35% in Q2 due to exceptionally strong Mexico and Germany sales in the prior-year quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glycorex Transplantation AB published the original content used to generate this news brief via Cision (Ref. ID: 202608280200BITN____UKPR__SV_20260827-BIT-3040-0) on August 28, 2026, and is solely responsible for the information contained therein.